Faculty profile

Stuart Peacock

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Stuart Peacock

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
5 publications in the last five years, latest in 2025.
Principal investigator on 5 research grants (5 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Health Technology Assessment Real World Evidence Health Services Research Annual Conference/Meeting Cancer Survivorship Knowledge Translation Societal Values And Public Engagement Cancer Drug Funding

Latest papers

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.
International journal of cancer · 2025
Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
BMJ Open · 2025
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.
Current oncology (Toronto, Ont.) · 2024

All 9 publications

Latest funding

The impact of childhood cancer on the socioeconomic outcomes of survivors and their families
CIHR · 2024 · Co-investigator
$100,000
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
CIHR · 2023 · Principal investigator
$10,000
Long COVID Web: Pan-Canadian Post-COVID Condition Research Network
CIHR · 2022 · Co-investigator
$19,999,614

All 13 grants and awards

9 publications.

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O'Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW, CanREValue Collaboration

International journal of cancer2025

DOI: 10.1002/ijc.35448 PMID: 40268528

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Chan KK-W, Takhar P, Evans WK, Mercer RE, Denburg A, Beca J, Muñoz C, Gavura S, Cheung WY, Hoch J

BMJ Open20254 citations

DOI: 10.1136/bmjopen-2024-096286

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Guan Q, Aktar SJ, Pataky RE, Stephen MM, Marques M, Gambaro K, Rachedi K, Forster K, Strub S, Stock D, de Léséleuc L, Cheung WY, Peacock S, Farrer C, Gavura S, Tadrous M, Grant RC, Chan KKW

Current oncology (Toronto, Ont.)2024

DOI: 10.3390/curroncol31060264 PMID: 38920747

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Parmar A, Dai WF, Dionne F, Geirnaert M, Denburg A, Ahuja T, Beca J, Bouchard S, Chambers C, Hunt MJ, Husereau D, Lungu E, McDonald V, Mercer RE, Mitera G, Muñoz C, Naipaul R, Peacock S, Potashnik T, Tadrous M, Takhar P, Taylor M, Trudeau M, Wasney D, Gavura S, Chan KKW

Current oncology (Toronto, Ont.)2023

DOI: 10.3390/curroncol30040286 PMID: 37185399

Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

Tsui TCO, Zeitouny S, Bremner KE, Cheung DC, Mulder C, Croxford R, Del Giudice L, Lapointe-Shaw L, Mendlowitz A, Wong WWL

CMAJ Open202210 citations

DOI: 10.9778/cmajo.20210328

A study protocol for a multicenter randomized pilot trial of a dyadic, tailored, web-based, psychosocial, and physical activity self-management program (TEMPO) for men with prostate cancer and their caregivers.

Lambert SD, Duncan LR, Ellis J, Robinson JW, Sears C, Culos-Reed N, Matthew A, De Raad M, Schaffler JL, Mina DS, Saha-Chaudhuri P, McTaggart-Cowan H, Peacock S

Pilot and feasibility studies2021Senior author

DOI: 10.1186/s40814-021-00791-6 PMID: 33743804

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis.

Khor S, Beca J, Krahn M, Hodgson D, Lee L, Crump M, Bremner KE, Luo J, Mamdani M, Bell CM, Sawka C, Gavura S, Sullivan T, Trudeau M, Peacock S, Hoch JS

BMC cancer2014

DOI: 10.1186/1471-2407-14-586 PMID: 25117912

Health care costs associated with hepatocellular carcinoma: a population-based study.

Thein HH, Isaranuwatchai W, Campitelli MA, Feld JJ, Yoshida E, Sherman M, Hoch JS, Peacock S, Krahn MD, Earle CC

Hepatology (Baltimore, Md.)2013

DOI: 10.1002/hep.26231 PMID: 23300063

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.

Jembere N, Campitelli MA, Sherman M, Feld JJ, Lou W, Peacock S, Yoshida E, Krahn MD, Earle C, Thein HH

PloS one2012

DOI: 10.1371/journal.pone.0040917 PMID: 22808283

The impact of childhood cancer on the socioeconomic outcomes of survivors and their families

Co-investigatorCIHR2024Project Grant - Priority Announcement - Cancer Survivorship

Principal investigators: Pechlivanoglou, Petros; Gupta, Sumit; Nathan, Paul C

Keywords: Childhood Cancer; Earning Potential; Educational Attainment; Impacts Of Chronic Disease On Family Units; Socioeconomic Burden Of Disease

$100,000

The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference

Principal investigatorCIHR2023Planning and Dissemination Grant - Institute Community Support

Principal investigators: Chan, Kelvin K; Peacock, Stuart J

Keywords: Annual Conference/Meeting; Cancer Survivorship; Health Services Research; Health Technology Assessment; Knowledge Translation; Societal Values And Public Engagement

$10,000

Long COVID Web: Pan-Canadian Post-COVID Condition Research Network

Co-investigatorCIHR2022Operating Grant: Canadian Post COVID-19 Condition Research Network

Principal investigators: Cheung, Angela M; Goulding, Susie E; Graves, Donna Lorraine; Archambault, Patrick; Awadalla, Philip; Bakal, Jeffrey A; Bhéreur, Anne; Brotto, Lori Anne; Busse, Jason W; Cameron, Jill I; Churchill, Katie; Crawley, Angela M; Décary, Simon; Durand, Madeleine; Falcone, Emilia L; Fowler, Robert A; Gommerman, Jennifer L; Graham, Kathryn E; Graham, Simon J; Groot, Gary; Gross, Douglas P; Guyatt, Gordon H; Halas, Gayle; Ho, Chester; Hohl, Corinne M; Holroyd, Brian R; Janjua, Naveed Z; Johnson, Pauline; Juando Prats, Clara; Kashuba, Sherri; Katz, Alan; Kho, Michelle E; Lam, Grace Y; Lamontagne, Francois; Langlois, Marc-Andre; Lavis, John N; Law, Susan K; LeBlanc, Annie; Levin, Adeera; Liu-Ambrose, Teresa Y; Liu, Peter P; Lix, Lisa M; Mandhane, Piush; Mann, Balraj; McGrail, Kimberlyn M; McNagny, Kelly M; Miciak, Maxi A; Mishra, Sharmistha; Muhajarine, Nazeem; Mukherjee, Manali; Mushquash, Christopher J; Nacul, Luis; O'Brien, Kelly K; Osgood, Nathaniel D; Papathanasoglou, Elisavet; Penninger, Josef; Piche, Alain; Pinto, Andrew D; Quinn, Kieran L; Rafferty, Ellen; Raj, Satish R; Razak, Fahad; Russell, James A; Sander, Beate H; Sekuler, Allison B; Soares, Claudio D; Tailfeathers, Esther; Tomlinson, George A; Tricco, Andrea C; Valdez, Yanet; Verma, Amol; Vohra, Sunita; Walmsley, Sharon L; Walsh, Jillian; Weeks, Laura C; Williams, Kienan; Wu, Jianhong; Yeung, Rae S

Keywords: Biobanking; Knowledge Translation; Long Covid; Mechanism Of Disease; National Network; Patient Engagement; Patient Registries; Post-Covid Condition; Research Communications; Social Determinants Of Health

$19,999,614

Developing a value framework for the assessment of precision cancer technologies for children

Co-investigatorCIHR2020Project Grant

Principal investigators: Denburg, Avram E

Keywords: Children And Youth; Health Care Priority-Setting; Health Systems; Health Technology Assessment; Pharmaceutical Policy; Precision Medicine; Value-Based Health Care

$321,300

The Response of Provincial Health Systems to COVID-19: Service Provision and Costs Across Health Sectors, First Nations and other populations

Co-investigatorCIHR2020Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Principal investigators: Krahn, Murray D; Kulkarni, Girish S

Keywords: Access To Health Care; Cost; Cost Effectiveness Analysis; Covid-19; Equity; First Nations; Indigenous Health; Quality Indicators; Regional Variation; Resource Use

$393,753

New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer

Co-investigatorCIHR2020Project Grant

Principal investigators: Kulkarni, Girish S; Krahn, Murray D

Keywords: Bladder Cancer; Cost-Effectiveness; Policy; Population Data; Technology; Therapy

$680,085

Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.

Co-investigatorCIHR2019Team Grant: CCS/CIHR Cancer Survivorship Team Grants

Principal investigators: Jones, Jennifer M

Keywords: Cancer; Clinical Trial; Feasibility; Implementation Science; Physical Function; Rehabilitation; Surveillance

$1,101,364

Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

Principal investigatorCIHR2017Operating Grant: PHSI for Cancer Control

Principal investigators: Chan, Kelvin K; Sherar, Michael D; Isaranuwatchai, Wanrudee; Peacock, Stuart J

Keywords: Cancer Drug Funding; Disinvestment; Framework Development; Health Services Research; Health Technology Assessment; Mixed Methods; Real World Evidence; Reassessment; Sustainbility

$970,638

A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma

Principal investigatorCIHR2016Catalyst Grant: Health Services and Economics Research in Cancer Control

Principal investigators: Chan, Kelvin K; Sherar, Michael D; Isaranuwatchai, Wanrudee; Peacock, Stuart J

Keywords: Health Technology Assessment; Real World Evidence

$98,925

Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

Principal investigatorCIHR2016Operating Grant: PHSI for Cancer Control - LOI

Principal investigators: Chan, Kelvin K; Sherar, Michael D; Peacock, Stuart J

Keywords: Health Technology Assessment; Real World Evidence

$19,474

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Stuart Peacock

Research

Latest papers

Latest funding

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study

A study protocol for a multicenter randomized pilot trial of a dyadic, tailored, web-based, psychosocial, and physical activity self-management program (TEMPO) for men with prostate cancer and their caregivers.

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis.

Health care costs associated with hepatocellular carcinoma: a population-based study.

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.

Frequent collaborators

Stuart Peacock

Mina Tadrous

Stuart Peacock

Avram Denburg

Maureen Trudeau

Claire de Oliveira

Wanrudee Isaranuwatchai

Lauren Lapointe-Shaw

Nathan Perlis

Beate Sander

Muhammad Mamdani

Beate Sander

Carol Mulder

David Hodgson

Helen Mctaggart-Cowan

Cynthia Kendell

Andrew Mendlowitz

Andrew Mendlowitz

Ning Liu

Wendy Lou

Terrence Sullivan

George Tomlinson

Murray Krahn

Erin Strumpf

Carol Sawka

Linda Lee

Jennifer Walker

Yvonne Bombard

Manon DE RAAD

Petros Pechlivanoglou

Robin Urquhart

William Evans